Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mayo

Showing results (221-230 of 302) with videos related to

Pageof 31
Sort By:
Journal of Thoracic Imaging|January 25, 2003
Detection of lung perfusion abnormalities using computed tomography in a porcine model of pulmonary embolismNicholas J Screaton, Harvey O Coxson, Steve E Kalloger, et al.
Radiology|July 31, 2004
Reduced radiation dose helical chest CT: effect on reader evaluation of structures and lung findingsJohn R Mayo, Kun-Il Kim, Sharyn L S MacDonald, et al.
Radiology|September 13, 2007
Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner SocietyMartine Remy-Jardin, Massimo Pistolesi, Lawrence R Goodman, et al.
Respirology (Carlton, Vic.)|February 9, 2010
Thoracic imagingDavid M Hansell, Phillip M Boiselle, Jonathan Goldin, et al.
British Journal of Clinical Pharmacology|December 17, 2013
Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporinSpencer Y Ling, Robert B Huizinga, Patrick R Mayo, et al.
Emergency Radiology|July 5, 2014
High pitch, low voltage dual source CT pulmonary angiography: assessment of image quality and diagnostic acceptability with hybrid iterative reconstructionPatrick D McLaughlin, T Liang, M Homiedan, et al.
American Journal of Nephrology|September 4, 2018
Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER StudyRajiv Agarwal, Patrick Rossignol, Dahlia Garza, et al.
Lancet (London, England)|September 20, 2019
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trialRajiv Agarwal, Patrick Rossignol, Alain Romero, et al.
Journal of Hypertension|January 28, 2017
Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diureticsMatthew R Weir, Martha R Mayo, Dahlia Garza, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 14, 2019
A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease ModelsJoseph Kuo, Michael Bobardt, Udayan Chatterji, et al.
Pageof 31

Showing results (221-230 of 302) with videos related to

Sort By:
Pageof 31
Journal of Thoracic Imaging|January 25, 2003
Detection of lung perfusion abnormalities using computed tomography in a porcine model of pulmonary embolismNicholas J Screaton, Harvey O Coxson, Steve E Kalloger, et al.
Radiology|July 31, 2004
Reduced radiation dose helical chest CT: effect on reader evaluation of structures and lung findingsJohn R Mayo, Kun-Il Kim, Sharyn L S MacDonald, et al.
Radiology|September 13, 2007
Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner SocietyMartine Remy-Jardin, Massimo Pistolesi, Lawrence R Goodman, et al.
Respirology (Carlton, Vic.)|February 9, 2010
Thoracic imagingDavid M Hansell, Phillip M Boiselle, Jonathan Goldin, et al.
British Journal of Clinical Pharmacology|December 17, 2013
Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporinSpencer Y Ling, Robert B Huizinga, Patrick R Mayo, et al.
Emergency Radiology|July 5, 2014
High pitch, low voltage dual source CT pulmonary angiography: assessment of image quality and diagnostic acceptability with hybrid iterative reconstructionPatrick D McLaughlin, T Liang, M Homiedan, et al.
American Journal of Nephrology|September 4, 2018
Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER StudyRajiv Agarwal, Patrick Rossignol, Dahlia Garza, et al.
Lancet (London, England)|September 20, 2019
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trialRajiv Agarwal, Patrick Rossignol, Alain Romero, et al.
Journal of Hypertension|January 28, 2017
Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diureticsMatthew R Weir, Martha R Mayo, Dahlia Garza, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 14, 2019
A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease ModelsJoseph Kuo, Michael Bobardt, Udayan Chatterji, et al.
Pageof 31